Compounds capable of activating cholinergic receptors

Details Compounds capable of activating cholinergic receptors Compounds capable of activating cholinergic receptors

2006-06-13

2006-06-13

Balasubramanian, Venkataraman (Department: 1624)

Organic compounds -- part of the class 532-570 series

Organic compounds

Nitrogen attached directly or indirectly to the purine ring...

C514S256000

Reexamination Certificate

active

07060826

ABSTRACT:
Compounds incorporating aryl substituted olefinic amine are provided. Representative compounds are (4E)-N-methyl-5-(3-pyridyl)-4-penten-2-amine, (4E)-N-methyl-5-(5-pyrimidinyl)-4-penten-2-amine, (4E)-N-methyl-5-(5-methoxy-3-pyridyl)-4-penten-2-amine, (4E)-N-methyl-5-(6-amino-5-methyl-3-pyridyl)-4-penten-2-amine, (2R)-(4E)-N-methyl-5-(3-pyridyl)-4-penten-2-amine, (2R)-(4E)-N-methyl-5-(5-isopropoxy-3-pyridyl)-4-penten-2-amine, (4E)-N-methyl-5-(5-bromo-3-pyridyl)-4-penten-2-amine, (4E)-N-methyl-5-(5-ethoxy-3-pyridyl)-4-penten-2-amine, (2S)-(4E)-N-methyl-5-(3-pyridyl)-4-penten-2-amine, (4E)-N-methyl-5-(5-isopropoxy-3-pyridyl)-4-penten-2-amine and (2S)-(4E)-N-methyl-5-(5-isopropoxy-3-pyridyl)-4-penten-2-amine.

REFERENCES:
patent: 4927838 (1990-05-01), Guthrie et al.
patent: 5212188 (1993-05-01), Caldwell et al.
patent: 5585388 (1996-12-01), Cosford et al.
patent: 5597919 (1997-01-01), Dull et al.
patent: 5604231 (1997-02-01), Smith et al.
patent: 5616707 (1997-04-01), Crooks et al.
patent: 5616716 (1997-04-01), Dull et al.
patent: 5616717 (1997-04-01), Grozinger
patent: 5629325 (1997-05-01), Lin et al.
patent: 5663356 (1997-09-01), Ruecroft et al.
patent: 5726316 (1998-03-01), Crooks et al.
patent: 5731314 (1998-03-01), Bencherif et al.
patent: 5811442 (1998-09-01), Bencherif et al.
patent: 5824692 (1998-10-01), Lippiello et al.
patent: 5861423 (1999-01-01), Caldwell et al.
patent: 5885998 (1999-03-01), Bencherif et al.
patent: 6107298 (2000-08-01), Bencherif et al.
patent: 6218383 (2001-04-01), Bencherif
patent: 6232316 (2001-05-01), Dull et al.
patent: 6262124 (2001-07-01), Dull et al.
patent: 6274606 (2001-08-01), Dull et al.
patent: 6455554 (2002-09-01), Dull et al.
patent: 6492399 (2002-12-01), Dull et al.
patent: 6531606 (2003-03-01), Dull et al.
patent: 6555684 (2003-04-01), Caldwell et al.
patent: 6603011 (2003-08-01), Caldwell et al.
patent: 0 559 495 (1993-09-01), None
patent: WO 96/20600 (1996-07-01), None
patent: WO 96/20929 (1996-07-01), None
patent: WO 96/31475 (1996-10-01), None
patent: WO 96/36637 (1996-11-01), None
patent: WO 97/40011 (1997-10-01), None
patent: WO 98/37071 (1998-08-01), None
Mirza et al., Psychopharmacology 148(3): 243-250, 2000.
Terry et al., Neuroscience 10192): 357-368, 2000.
Court et al., J. Chem. Neuroanat. 20(3-4): 281-298, 2000.
Cooper, D.A. and J.M. Moore, “Femtogram on column detection of nicotine by isotope dilution gas chromatography
egative ion detection mass spectrometry,”Biol. Mass. Spectrom., 22(10): 590-594 (1993).
Loffler, K., et al.,Chem. Ber., 42:3431-3488 (1909).
LaForge, F.B., “The preparation and properties of some new derivatives of pyridine,”J. Am. Chem. Soc., 50: 2477-2483 (1928).
Pinner, A.,Chem. Ber., pp. 2861-2870 (1894).
Malek, N., et al.,J. Org. Chem., 47: 5395-5397 (1982).
Joyce, N.J., et al.,Heterocycles, 29(7): 2947-2949 (1978).
Frank, W., et al., “Palladium-Catalyzed Vinylic Substitution Reactions with Heterocyclic Bromides,”J. Org. Chem., 43(15): 2947-2949 (1978).
Sprouse, C., et al.,Abstracts of Papers, Coresta/TCRC, Joint Conference, pp. 32 (1972).
Pinner, A.,Chem. Ber., 1053-1061 (1894).
Acheson, R., et al., “Transformations involving the Pyrrolidine Ring of Nicotine,”J. Chem. Soc. Perkin Trans., 1: 579-585 (1980).
Bleicher, L. and N.D.P. Cosford, “Aryl-and Heteroaryl-Alkyne Coupling Reactions Catalyzed by Palladium on Carbon and CuI in an Aqueous Medium,”Synlett, 115-1116 (1995).
Lippiello, P., et al., “RJR-2403: A Nicotinic Agonist with CNS Selectivity I. In Vitro Characterization,”JPET, 279(3): 422-1429 (1996).
Bencherif, M., et al., “RJR-2403: A Nicotinic Agonist with CNS Selctivity II. In Vitro Characterization,”JPET, 279(3): 1413-1421 (1996).
Hogberg, Thomas, et al., “Homallylic Amines Related to Zimeldine. A Comparative Study on Neuronal Seroonin and Norepinephrine Reuptake Based on Conformational Analysis,”J. Med. Chem., 31: 913-919 (1988).
International Search Report; Nov. 26, 1999; R.J. Reynolds Tobacco Company, et al.; PCT/US99/12340.
Arneric, S. and M. Williams, “Nicotinic Agonists in Alzheimer's Disease: Does the Molecular Diversity of Nicotine Receptors Offer the Opportunity for Developing CNS-Selective Cholinergic Channel Activators?,”Int. Acad. Biomed. Drug Res., 7: 58-70 (1994).
Bencherif, et al., “Metanicotine: A Nicotinic Agonist with CNS Selectivity—In Vitro Characterization,”Society for Neuroscience Abstracts, 21(1-3): 605 (1995).
Perry, E.K., et al., “Alteration in Nicotine Binding Sites in Parkinson's Disease, Lewy Body Dementia and Alzheimer's Disease: Possible Index of Early Neuropathology,”Neuroscience, 64(2): 385-395 (1995).
Sahakian, B. and J. Coull, “Nicotine and Tetrahydroaminoacradine: Evidence for Improved Attention in Patients with Dementia of the Alzheimer Type,”Drug Development Research, 31: 80-88 (1994).
Wilson, K.L., Jr., et al., “Nicotine-Like Actions of cis-Metanicotine and trans-Metanicotine,”The Journal of Pharmacology and Experimental Therapeutics, 196(3): 685-696 (1976).

Affiliated with

Also associated with

Rating

Compounds capable of activating cholinergic receptors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds capable of activating cholinergic receptors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds capable of activating cholinergic receptors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3639563